Evidence map›Paper›PMID 40507824›Full record

ArticleInternational journal of molecular sciences2025

Jamila Alessandra Perini, Raphael Wallace Campos Cunha, Marco Bernardo Cury Fernandes, Lourenço Pinto Peixoto, João Antônio Matheus Guimarães, Amanda Dos Santos Cavalcanti, Jéssica Vilarinho Cardoso

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. TheGenes · 2025
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jamila Alessandra PeriniResearch Laboratory of Pharmaceutical Sciences (LAPESF), Rio de Janeiro State University (UERJ), Rio de Janeiro 23070-200, RJ, Brazil.ORCID 0000-0002-7683-0698
Raphael Wallace Campos CunhaHip Surgery Center, National Institute of Traumatology and Orthopaedics (INTO), Rio de Janeiro 20940-070, RJ, Brazil.
Marco Bernardo Cury FernandesHip Surgery Center, National Institute of Traumatology and Orthopaedics (INTO), Rio de Janeiro 20940-070, RJ, Brazil.
Lourenço Pinto PeixotoHip Surgery Center, National Institute of Traumatology and Orthopaedics (INTO), Rio de Janeiro 20940-070, RJ, Brazil.
João Antônio Matheus GuimarãesResearch Division, INTO, Rio de Janeiro 20940-070, RJ, Brazil.ORCID 0000-0002-4088-044X
Amanda Dos Santos CavalcantiResearch Laboratory of Pharmaceutical Sciences (LAPESF), Rio de Janeiro State University (UERJ), Rio de Janeiro 23070-200, RJ, Brazil.ORCID 0000-0002-8792-7524
Jéssica Vilarinho CardosoResearch Laboratory of Pharmaceutical Sciences (LAPESF), Rio de Janeiro State University (UERJ), Rio de Janeiro 23070-200, RJ, Brazil.

Funding

Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro E-26/210.949/2021
6 · The paper itself

Abstract

Developmental dysplasia of the hip (DDH) is a multifactorial and polygenic abnormal hip joint development, with a prognosis influenced by environmental and genetic factors, potentially leading to complete dislocation. Growth differentiation factor 5 is a signaling molecule, encoded by a polymorphic gene (

Indexed as

Developmental Dysplasia of the HipGenetic Predisposition to DiseaseGrowth Differentiation Factor 5Polymorphism, Single NucleotideAdultBrazilCase-Control StudiesChildFemaleGene FrequencyGenotypeHumansMaleGDF5 protein, humanGrowth Differentiation Factor 5GDF5 genegenetic polymorphismmusculoskeletal diseases

Identifiers

PMID40507824
PMCPMC12155270

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.